21 окт. 2024 г. · Catalent's acquisition by Novo Holdings is expected to close towards the end of calendar year 2024, subject to customary closing conditions.

30 окт. 2024 г. · Roche recently joined naysayers who argue the deal threatens competition in the burgeoning weight loss and diabetes drug market.

5 нояб. 2024 г. · Catalent posted a quarterly adjusted loss of 13 cents per share. Analysts were expecting a profit of 5 cents.

NEWS & EVENTS · IsomAb Announces Strategic Collaboration with Catalent · Catalent Issues Open Letter to Customers Regarding Pending Acquisition by Novo Holdings.

7 дней назад · Don't expect Novo-Catalent merger investigation to fizzle out under the new Trump administration · As a former policy director of the FTC, I ...

24 окт. 2024 г. · Novo Holdings announced the $16.5 billion acquisition of Catalent, a deal that would ultimately see Novo Nordisk taking manufacturing sites for $11 billion.

3 мая 2024 г. · Earlier this year, Novo Holdings unveiled its plan to buy out Catalent for $16.5 billion following months of speculation that the CDMO had ...

4 нояб. 2024 г. · EU antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings' acquisition of contract drug manufacturer Catalent (CTLT.N).

8 нояб. 2024 г. · Novo Holdings' $16.5 billion acquisition of CDMO giant Catalent continues to be under antitrust scrutiny by global regulators.

Catalent to sell New Jersey drug facility to Ardena The acquisition aims to boost Ardena's small-scale manufacturing for commercial oral drug products.